Eton Pharmaceutcials
ETON
87 hedge funds and large institutions have $243M invested in Eton Pharmaceutcials in 2025 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 35 increasing their positions, 19 reducing their positions, and 25 closing their positions.
2,574% more call options, than puts
Call options by funds: $4.54M | Put options by funds: $170K
84% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 19
28% more capital invested
Capital invested by funds: $190M → $243M (+$53.6M)
9.17% more ownership
Funds ownership: 54.49% → 63.66% (+9.2%)
1% more funds holding
Funds holding: 86 → 87 (+1)
4% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 25
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$18.8M |
| 2 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
+$7.87M |
| 3 |
Morgan Stanley
New York
|
+$5.73M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.66M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$4.51M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$6.61M |
| 2 |
CC
Cannell Capital
Alta,
Wyoming
|
-$4.79M |
| 3 |
Millennium Management
New York
|
-$4.62M |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
-$3.35M |
| 5 |
MBAM
Mink Brook Asset Management
West Palm Beach,
Florida
|
-$2M |
ETON Hedge Fund Activity: Q2 2025 in Review
87 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Eton Pharmaceutcials (ETON) for Q2 2025, worth a combined $243M — up 28% from $190M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new ETON positions and 25 closed out — a net gain of 1 holder — while 35 added to existing stakes and 19 trimmed.
The largest buyer was BlackRock, adding an estimated $18.8M. The largest seller was Susquehanna International Group, cutting an estimated $6.61M.
- 87 institutional investors held Eton Pharmaceutcials (ETON) as of Q2 2025, up from 86 in Q1 2025.
- Funds reported $243M of Eton Pharmaceutcials stock for Q2 2025, up 28% quarter-over-quarter.
- 26 funds opened new Eton Pharmaceutcials positions in Q2 2025 and 25 closed out, a net change of +1 holder.
- The largest Eton Pharmaceutcials buyer in Q2 2025 was BlackRock, an estimated $18.8M added.
- The largest Eton Pharmaceutcials seller in Q2 2025 was Susquehanna International Group, an estimated $6.61M sold.
Based on aggregated 13F filings for Q2 2025.